FOSUN PHARMA (02196) announced that (1) Mr. Wu Yifang has resigned from his position as non-executive director due to personal career adjustments, with the resignation taking effect from September 30, 2025; and (2) the company proposes to appoint Mr. Liu Yi as an executive director of the tenth board of directors.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.